CALR and neoplasm: Treatment of cancerous cells in vitro increased tumor immunogenicity through the emission of multiple danger signals such as surface‐exposed calreticulin (CRT), secreted adenosine triphosphate (ATP), and released high mobility group box protein 1 (HMGB1).15, 16, 17, 18